Screening for mumps immunity with the microtiter solid-phase radioimmunoassay. 1976

R Hernandez, and M Just, and A Bürgin-Wolff

A solid phase radioimmunoassay on microtiter plates was adapted for the estimation of mumps antibodies using commercially available complement-fixing mumps antigen. The sensitivity of the test is superior to that of hemagglutination inhibition and lies in the same range as the virus neutralization test performed on chick fibroblasts. The method is useful for screening large series of human sera, for instance in connection with vaccination programs.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D009107 Mumps An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed) Parotitis, Epidemic,Epidemic Parotitides,Epidemic Parotitis,Parotitides, Epidemic
D009109 Mumps virus The type species of RUBULAVIRUS that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection. Epidemic Parotitis Virus,Myxovirus parotitidis,Epidemic Parotitis Viruses,Mumps viruses
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

R Hernandez, and M Just, and A Bürgin-Wolff
April 1981, The Journal of allergy and clinical immunology,
R Hernandez, and M Just, and A Bürgin-Wolff
October 1973, Applied microbiology,
R Hernandez, and M Just, and A Bürgin-Wolff
March 1981, Annals of allergy,
R Hernandez, and M Just, and A Bürgin-Wolff
March 1983, The Journal of laboratory and clinical medicine,
R Hernandez, and M Just, and A Bürgin-Wolff
February 1976, Journal of immunology (Baltimore, Md. : 1950),
R Hernandez, and M Just, and A Bürgin-Wolff
February 1983, Journal of clinical microbiology,
R Hernandez, and M Just, and A Bürgin-Wolff
March 1975, Nihon Naibunpi Gakkai zasshi,
R Hernandez, and M Just, and A Bürgin-Wolff
September 1977, Infection and immunity,
R Hernandez, and M Just, and A Bürgin-Wolff
March 1972, Naika hokan. Japanese archives of internal medicine,
R Hernandez, and M Just, and A Bürgin-Wolff
April 1977, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!